NCT06160908View on ClinicalTrials.gov

Transcranial Near-infrared Light Therapy for Mild-Moderate Alzheimer's Disease (NIR4AD)

NAActive, not recruitingINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

December 12, 2023

Primary Completion Date

August 25, 2024

Study Completion Date

June 30, 2026

Conditions
Alzheimer Disease
Interventions
DEVICE

NirsCure

True near-infrared light； Once a day, once for 30 minutes, 6 times a week

DEVICE

sham NirsCure

Non near-infrared light irradiation；only the equipment appearance is consistent with the test device；Once a day, once for 30 minutes, 6 times a week

DEVICE

NirsCure

True near-infrared light； Once a day, once for 30 minutes, 6 times a week

Trial Locations (1)

100053

Xuanwu Hospital, Capital Medical University, Beijing

All Listed Sponsors
collaborator

Danyang Huichuang Medical Equipment Co., Ltd.

INDUSTRY

lead

Xuanwu Hospital, Beijing

OTHER

NCT06160908 - Transcranial Near-infrared Light Therapy for Mild-Moderate Alzheimer's Disease (NIR4AD) | Biotech Hunter | Biotech Hunter